Table 6. Incremental cost-effective ratios (cost per DALY averted) for vaccination of children 1–14 years and rank of influence when key variables are varied, by vial size (US$).
Variable | Type of Distribution and Parameters | Minimum | Maximum | Rank of influence |
---|---|---|---|---|
Single dose vials | ||||
Case fatality rate | Beta, α1 = 15; α2 = 985 | $557 | $1,545 | 1 |
Incidence | Beta, α1 = 23, α2 = 977 | $570 | $1,476 | 2 |
Treatment cost | Gamma, α = 6.82; β = 136 | $773 | $1,077 | 3 |
Vaccine price | Gamma α = 16; β = 5.6 | $831 | $1,021 | 4 |
Vaccine delivery cost | Gamma, α = 70; β = 7 | $834 | $1,018 | 5 |
Ten dose vials | ||||
Case fatality rate | Beta, α1 = 15; α2 = 985 | $400 | $1,109 | 1 |
Incidence | Beta, α1 = 23, α2 = 977 | $396 | $1,070 | 2 |
Treatment cost | Gamma, α = 6.82; β = 136 | $557 | $771 | 3 |
Vaccine delivery cost | Gamma, α = 70; β = 7 | $574 | $754 | 4 |
Vaccine price | Gamma, α = 16; β = 5.6 | $582 | $746 | 5 |